Colossal Biosciences has revealed its latest creation, genetically engineered dire wolves, amidst a $10 billion valuation. These animals, based on ancient DNA, are being questioned by scientists regarding their true status as de-extinct species. Co-founder Ben Lamm defends the project, emphasizing both the scientific advancements and ethical considerations taken during the gene editing process. Critics argue that these hybrids do not represent a genuine revival of the species, sparking debate within the scientific community. Colossal aims to pair de-extinction efforts with conservation projects, particularly focusing on red wolves.